Epoetin zeta

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameEpoetin zeta
Drug Alias NameErythropoietin alfa biosimilar (Stada Arzneimittel)Epoetin alfa biosimilar (Stada Arzneimittel)Darbepoetin alfa biosimilar (Stada Arzneimittel)Darbepoetin biosimilar (Stada Arzneimittel)Epoetin biosimilar (Stada Arzneimittel) +[12] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaKidney Failure, ChronicCardio-Renal Syndrome +[4] 
Global Approved IndicationsAnemiaKidney Failure, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2007/12/18
Country/TerritoryUnited StatesPuerto RicoEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBioceuticals Arzneimittel Ag
China Registration ClassN/A

Develop Information

Active CompaniesHospira IncStada Arzneimittel AgPfizer Europe Ma Eeig
Inactive CompaniesHospiraPfizer Inc
Active IndicationsAnemiaKidney Failure, Chronic
Inactive IndicationsCardio-Renal SyndromeRenal Insufficiency

Other Information

ATC CodeB03XA01
Related LinksDrugBankKEGG